SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-15-000189
Filing Date
2015-11-06
Accepted
2015-11-06 17:06:52
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20150930x10q.htm 10-Q 857677
2 CEO CERTIFICATION nlnk-20150930xex311.htm EX-31.1 12245
3 CFO CERTIFICATION nlnk-20150930xex312.htm EX-31.2 12242
4 SECTION 1350 CERTIFICATION nlnk-20150930xex321.htm EX-32.1 8649
11 GRAPHIC newlinklogorgbwtaga01a01a03.jpg GRAPHIC 245252
  Complete submission text file 0001126234-15-000189.txt   3473960

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nlnk-20150930.xml EX-101.INS 343540
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20150930.xsd EX-101.SCH 29674
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20150930_cal.xml EX-101.CAL 46539
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20150930_def.xml EX-101.DEF 150315
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20150930_lab.xml EX-101.LAB 411526
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20150930_pre.xml EX-101.PRE 213729
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 151213195
SIC: 2834 Pharmaceutical Preparations